Milgamma Protekt, 30-90 tablets.
Milgamma Protekt with benfotiamine for the treatment of nerve damage resulting from a vitamin B1 deficiency. In this way, foot problems such as tingling, burning or numbness can be alleviated.
Milgamma Protekt can compensate for the vitamin B1 deficiency and alleviate the symptoms. What is special is the active ingredient benfotiamine. The fat-soluble precursor of vitamin B1 is absorbed by the body 5 times better than “simple” vitamin B1 (thiamine).
Instructions / dosage:
The recommended dose is 1 film-coated tablet once a day.
For the therapy of neuropathies, the preparation should initially be taken over a period of at least 3 weeks. Further treatment is then carried out according to the therapeutic success.
Ingredients
The active ingredient is: 1 film-coated tablet contains 300 mg of benfotiamine (fat-soluble vitamin B1 derivative). The other ingredients are: microcrystalline cellulose, talc, povidone (K30), highly dispersed silicon dioxide, croscarmellose sodium, higher chain partial glycerides, hypromellose, titanium dioxide, polyethylene glycol, saccharin - sodium
Do not exceed the recommended daily dose. Store in a dry, dark place, out of the reach of children below 25°C / 77°F.
Disclaimer! This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.
Milgamma Protekt with benfotiamine for the treatment of nerve damage resulting from a vitamin B1 deficiency. In this way, foot problems such as tingling, burning or numbness can be alleviated.
Milgamma Protekt can compensate for the vitamin B1 deficiency and alleviate the symptoms. What is special is the active ingredient benfotiamine. The fat-soluble precursor of vitamin B1 is absorbed by the body 5 times better than “simple” vitamin B1 (thiamine).
Instructions / dosage:
The recommended dose is 1 film-coated tablet once a day.
For the therapy of neuropathies, the preparation should initially be taken over a period of at least 3 weeks. Further treatment is then carried out according to the therapeutic success.
Ingredients
The active ingredient is: 1 film-coated tablet contains 300 mg of benfotiamine (fat-soluble vitamin B1 derivative). The other ingredients are: microcrystalline cellulose, talc, povidone (K30), highly dispersed silicon dioxide, croscarmellose sodium, higher chain partial glycerides, hypromellose, titanium dioxide, polyethylene glycol, saccharin - sodium
Do not exceed the recommended daily dose. Store in a dry, dark place, out of the reach of children below 25°C / 77°F.
Disclaimer! This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The picture is for illustration only. The packaging can be changed by the manufacturer. All packs include English informational leaflet.
LT, Vilnius